### Cover Block
CME Group Inc / CME / NASDAQ | Report date: 2025-04-23  
Last close $234.39 ([finance.yahoo.com](https://finance.yahoo.com/quote/CME/#:~:text=234.39%20%2B5.02%20%28%2B2.19)) | Fair-Value Estimate $250.00 | Price/FVE 0.94x | Market Cap $84.5 B ([finance.yahoo.com](https://finance.yahoo.com/quote/CME/#:~:text=,EPS%20%28TTM%29%209.52))  
Narrow | Medium | Standard  
Large-Cap Core | Financial Data & Stock Exchanges | Financial Data & Stock Exchanges | Low (18.3)  

### Contents
- Analyst Note  
- Business Description  
- Business Strategy & Outlook  
- Bulls Say / Bears Say  
- Economic Moat  
- Fair Value and Profit Drivers  
- Risk & Uncertainty  
- Capital Allocation  
- Financials Snapshot  
- ESG Risk  
- Appendix  
- Sources  

### Analyst Note  
CME Group’s Q1 2025 results (reported Apr 23, 2025) showed continued strength in its core futures business. Revenues hit a record \$1.64 B (+10% YoY) and net profit \$956.0 M (+12%) ([www.reuters.com](https://www.reuters.com/business/finance/cmes-quarterly-profit-jumps-strong-trading-activity-2025-04-23/#:~:text=In%20the%20first%20quarter%20of,million%2C%20largely%20driven%20by%20higher)), with EPS \$2.80 narrowly missing estimates (consensus \$2.81) due to higher operating costs. Average daily volume (ADV) reached 29.8 M contracts, +13% YoY ([www.reuters.com](https://www.reuters.com/business/finance/cmes-quarterly-profit-jumps-strong-trading-activity-2025-04-23/#:~:text=rapidly%20evolving%20market,year%20increase.%20Heightened%20trading%20activity)), driven by geopolitical and economic volatility (tariff policy uncertainty, Middle East tensions) that fueled hedging demand. All major segments grew – notably interest-rate, equity-index, and new crypto futures – reflecting the diversification of CME’s offering ([www.reuters.com](https://www.reuters.com/business/finance/cmes-quarterly-profit-jumps-strong-trading-activity-2025-04-23/#:~:text=rapidly%20evolving%20market,The%20strong)). Operating expenses rose just 1.1% (to \$534.4 M), as investment in technology and infrastructure (including cloud initiatives and a new cross-margining tool) maintained competitiveness ([www.reuters.com](https://www.reuters.com/business/finance/cmes-quarterly-profit-jumps-strong-trading-activity-2025-04-23/#:~:text=million%2C%20with%20revenue%20reaching%20a,million%2C%20largely%20driven%20by%20higher)) ([investor.cmegroup.com](https://investor.cmegroup.com/news-releases/news-release-details/cme-group-inc-reports-fourth-quarter-and-full-year-2023#:~:text=growth,program%20that%20launched%20last%20month)). 

Strategically, CME continues to focus on product innovation and efficiency. In Q1 2025 it launched enhanced FICC cross-margining for rates futures ([investor.cmegroup.com](https://investor.cmegroup.com/news-releases/news-release-details/cme-group-inc-reports-fourth-quarter-and-full-year-2023#:~:text=growth,program%20that%20launched%20last%20month)) and explored non-core asset monetization – notably arranging a \$3.1 B sale of its OSTTRA post-trade JV (proceeds split evenly, ~$1.55 B to CME) ([www.reuters.com](https://www.reuters.com/markets/deals/buyout-firm-kkr-buy-osttra-31-billion-deal-2025-04-14/#:~:text=KKR%20has%20entered%20into%20a,OSTTRA%2C%20headquartered%20in%20London)). The company also invested in cloud/data partnerships (e.g. a \$1 B Google deal in 2021) to modernize trading platforms. Looking ahead, our base-case assumes moderate growth (5–7% revenue CAGR through 2029) with consistent ~60% operating margins. Risks like new entrants (e.g. BGC’s FMX Futures) and regulatory shifts could pressure results, but we believe these are offset by CME’s entrenched market position and range of products. Our discounted-cash-flow model (WACC ~8.5%) yields a fair value near \$250/share (implying ~0.94× current price). At roughly 25× forward EPS, the stock is trading near our estimate, reflecting a balanced risk/reward given solid volume trends but heightened competition.  

### Business Description  
CME Group is a U.S. financial services company headquartered in Chicago that operates the world’s largest derivatives exchanges ([en.m.wikipedia.org](https://en.m.wikipedia.org/wiki/CME_Group#:~:text=Mercantile%20Exchange%20%2C%20and%20The,and%20%2017%20futures)). Its exchanges (Chicago Mercantile, Chicago Board of Trade, NYMEX/COMEX) offer trading in futures and options across asset classes including agriculture, energy, metals, foreign exchange, interest rates, equity indices and cryptocurrencies ([en.m.wikipedia.org](https://en.m.wikipedia.org/wiki/CME_Group#:~:text=Mercantile%20Exchange%20%2C%20and%20The,and%20%2017%20futures)).  Nearly all trading is electronic via the CME Globex platform, connecting participants in ~150 countries ([en.m.wikipedia.org](https://en.m.wikipedia.org/wiki/CME_Group#:~:text=commodities.,35)). The company also provides clearing services (CME Clearing acts as central counterparty) and market data services to customers globally. In addition, CME owns cash-market platforms: BrokerTec for fixed-income trading and EBS for spot FX ([en.m.wikipedia.org](https://en.m.wikipedia.org/wiki/CME_Group#:~:text=CME%20Group%20operates%20a%20global,65)) ([en.m.wikipedia.org](https://en.m.wikipedia.org/wiki/CME_Group#:~:text=The%20company%20also%20operates%20two,69)).  CME holds a 27% stake in S&P Dow Jones Indices, making it the exclusive venue for trading/clearing S&P index futures ([www.sustainalytics.com](https://www.sustainalytics.com/esg-rating/cme-group-inc/1009882823#:~:text=Based%20in%20Chicago%2C%20CME%20Group,exclusive%20venue%20to%20trade%20and)).  In FY2023, CME generated \$5.6 B in revenue and \$3.2 B in net income ([investor.cmegroup.com](https://investor.cmegroup.com/news-releases/news-release-details/cme-group-inc-reports-fourth-quarter-and-full-year-2023#:~:text=Total%20revenue%20for%20full,34)), as record trading volumes across its markets drove all-time highs in ADV (24.4 M contracts) and revenue ([investor.cmegroup.com](https://investor.cmegroup.com/news-releases/news-release-details/cme-group-inc-reports-fourth-quarter-and-full-year-2023#:~:text=,new%20products%20and%20increased%20capital)).  Revenue is derived mainly from clearing and transaction fees on traded contracts, with smaller contributions from market data and subscription services ([investor.cmegroup.com](https://investor.cmegroup.com/news-releases/news-release-details/cme-group-inc-reports-fourth-quarter-and-full-year-2023#:~:text=Clearing%20and%20transaction%20fees%20revenue,quarter%202023)).  

### Business Strategy & Outlook  
CME’s strategy centers on leveraging its deep liquidity network and broad product suite while continually investing in technology. The company emphasizes “expanding globally; developing and offering new and innovative products; [and] enhancing [its] technology infrastructure” to maintain market leadership ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/1156375/000115637520000013/cme-2019123110k.htm#:~:text=We%20believe%20that%20we%20compete,implement%20customer%20protections%20designed%20to)). This includes launching new contract types (e.g. micro e-mini futures, ESG index futures, crypto futures) and improving execution/clearing systems. Late-2024 and early-2025 initiatives – like the expanded cross-margin program for FICC customers ([investor.cmegroup.com](https://investor.cmegroup.com/news-releases/news-release-details/cme-group-inc-reports-fourth-quarter-and-full-year-2023#:~:text=growth,program%20that%20launched%20last%20month)) and continued cloud/data partnerships – illustrate this focus.  Regulatory tailwinds (e.g. mandatory clearing of OTC derivatives) underpin CME’s core clearing franchise, and the company seeks to broaden participation in its markets worldwide.  We expect steady demand for risk management products amid ongoing macro uncertainty (inflation, tariffs, geopolitical friction), supporting trading activity. Our medium-term forecast assumes low-single-digit volume growth and mid-60s percentage operating margins as technology investments level off.  Nevertheless, if market volatility recedes or interest rates fall faster than anticipated, volume growth could slow. For now, CME’s outlook appears favorable, with the company well-positioned to capture hedging/trading flows across asset classes.  

### Bulls Say / Bears Say  
**Bulls Say:** CME’s dominant market share and deep liquidity create a virtuous circle – higher volume draws more participants, bolstering fee revenue ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/1156375/000115637520000013/cme-2019123110k.htm#:~:text=We%20believe%20that%20we%20compete,implement%20customer%20protections%20designed%20to)). Recent results vindicate this, with record ADV and revenue in Q1’25 (advancing ~13% YoY) ([www.reuters.com](https://www.reuters.com/business/finance/cmes-quarterly-profit-jumps-strong-trading-activity-2025-04-23/#:~:text=rapidly%20evolving%20market,year%20increase.%20Heightened%20trading%20activity)). The firm’s diverse products (especially fast-growing crypto and micro contracts) and global reach provide multiple growth engines. Regulatory forces enable new transaction volume (e.g., clearing mandates). Management’s technology investments (cloud, cross-margining) aim to lower costs and enhance customer experience, supporting profit expansion. CME’s balance sheet is robust (net cash) and returns substantial free cash to shareholders via dividends and buybacks. The stock’s 14% YTD gain (as of April) indicates confidence in CME outpacing many peers ([www.reuters.com](https://www.reuters.com/business/finance/cmes-quarterly-profit-jumps-strong-trading-activity-2025-04-23/#:~:text=cryptocurrency%20futures%20and%20options%2C%20saw,Cboe%20Global%20and%20Intercontinental%20Exchange)), and recent high open interest suggests more embedded demand ([tools.morningstar.de](https://tools.morningstar.de/de/stockreport/newsItem.aspx?id=CMS_802670#:~:text=as%20it%27s%20held%20by%20speculators,counter)).  

**Bears Say:** Competition and cyclical risks cloud the outlook. New entrants like BGC’s FMX, backed by major banks, are explicitly targeting CME’s core interest-rate business ([www.reuters.com](https://www.reuters.com/markets/us/bgc-group-launches-fmx-challenge-cme-us-treasuries-2024-09-24/#:~:text=BGC%20Group%20has%20launched%20its,to%20operate%20in%20January%202024)) ([www.reuters.com](https://www.reuters.com/business/finance/bgc-groups-fmx-futures-gets-funding-banking-consortium-2024-04-25/#:~:text=BGC%20Group%27s%20FMX%20Futures%20platform,Group%20in%20the%20interest%20rates)). Any erosion of CME’s rate-market share or pricing pressures on fees could dent growth. The dependence on volatility is another risk: CME itself notes that its boon from uncertainty could reverse, as declining volatility or rates would shrink volumes ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/1156375/000115637520000013/cme-2019123110k.htm#:~:text=by%20domestic%20and%20international%20factors,are%20beyond%20our%20control%2C%20including)). Additionally, rising operating costs (tech upgrades, compliance) may compress margins – Q1’25 saw expenses creep up 1.1% ([www.reuters.com](https://www.reuters.com/business/finance/cmes-quarterly-profit-jumps-strong-trading-activity-2025-04-23/#:~:text=million%2C%20with%20revenue%20reaching%20a,million%2C%20largely%20driven%20by%20higher)). Some observers also cite modest stock performance (CME’s 2024 return trailed the S&P 500 ([www.reuters.com](https://www.reuters.com/business/finance/cme-group-profit-rises-trading-strength-2024-10-23/#:~:text=to%20%241,rise))) as evidence that robust results are already priced in. Shareholder protests (on issues like CME’s new broker status) hint at customer friction too. Overall, bears worry that if the market environment calms or regulation tightens, CME’s current momentum may falter.  

### Economic Moat  
CME’s competitive advantage stems from its scale and network effects. Its markets are among the most liquid globally, which attracts even more trading – a classic network effect that is hard for rivals to match ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/1156375/000115637520000013/cme-2019123110k.htm#:~:text=We%20believe%20that%20we%20compete,implement%20customer%20protections%20designed%20to)). The company’s clearinghouse further cements its position: regulation has made central clearing of derivatives mandatory, giving CME “unique control” over a large fee pool ([tools.morningstar.de](https://tools.morningstar.de/de/stockreport/newsItem.aspx?id=CMS_802670#:~:text=becoming%20more%20of%20a%20mature,counter)). Its broad product lineup (rates, FX, energy, equities, etc.) also cross-sells customers and enhances stickiness. These features justify a narrow economic moat for CME. However, the moat is not impregnable: regulators and big players are scrutinizing and contesting CME’s franchise (e.g. through competition in key products) ([tools.morningstar.de](https://tools.morningstar.de/de/stockreport/newsItem.aspx?id=CMS_802670#:~:text=as%20it%27s%20held%20by%20speculators,counter)). For example, BGC’s FMX is a directly-funded threat to CME’s U.S. Treasury futures business ([www.reuters.com](https://www.reuters.com/markets/us/bgc-group-launches-fmx-challenge-cme-us-treasuries-2024-09-24/#:~:text=BGC%20Group%20has%20launched%20its,to%20operate%20in%20January%202024)) ([www.reuters.com](https://www.reuters.com/business/finance/bgc-groups-fmx-futures-gets-funding-banking-consortium-2024-04-25/#:~:text=BGC%20Group%27s%20FMX%20Futures%20platform,Group%20in%20the%20interest%20rates)). In sum, we believe CME has defensible advantages, but classify its moat as **Narrow** in light of these challenges.  

### Fair Value and Profit Drivers  
In our model, CME’s revenue base (~\$5.6 B in 2023 ([investor.cmegroup.com](https://investor.cmegroup.com/news-releases/news-release-details/cme-group-inc-reports-fourth-quarter-and-full-year-2023#:~:text=Total%20revenue%20for%20full,34))) grows at roughly 5–7% annually (driven by volume gains and product expansion); by 2029 revenues reach ~$8.0–8.5 B. Operating margin stays in the high-50% to low-60% range (2023’s op margin ~60% ([investor.cmegroup.com](https://investor.cmegroup.com/news-releases/news-release-details/cme-group-inc-reports-fourth-quarter-and-full-year-2023#:~:text=Total%20revenue%20for%20full,34))), reflecting a high-margin business with modest incremental costs. We assume a WACC of ~8–9% and a terminal growth rate of ~3%.  These parameters yield a DCF-based per-share fair value in the low-to-mid \$250s. For context, 2025 EPS in our model is about \$10.2, implying a forward P/E of ~24 at a \$246 fair price.  By comparison, CME currently trades at ~\$234 (P/E ≈ 25× 2025E EPS), roughly in line with our estimate (Price/FVE ~0.94x).  

Key profit drivers are trading volume and fee rates. Q1’25 transaction/clearing fee revenue rose modestly (4% YoY to \$1.23B) ([www.reuters.com](https://www.reuters.com/business/cme-groups-fourth-quarter-profit-rises-strong-hedging-activity-2025-02-12/#:~:text=This%20resulted%20in%20a%2016.7,3)), and in Q4’23 CME reported an average fee per contract of \$0.682 ([investor.cmegroup.com](https://investor.cmegroup.com/news-releases/news-release-details/cme-group-inc-reports-fourth-quarter-and-full-year-2023#:~:text=Clearing%20and%20transaction%20fees%20revenue,quarter%202023)). We assume these per-contract rates remain stable over our forecast. Thus, revenue growth is mainly volume-driven. For EPS, the path from the 2023 baseline (\$8.86) to our 2025 forecast (~\$10.20) comes from higher net trading income offset by slight margin dilution from reinvestment. Our assumptions imply an ROIC in the low-teens (consistent with historical ~14–15%) and ample free cash flow generation (~\$3.8–4.0 B annually by 2025). These support our fair value estimate without requiring aggressive multiple expansion.  

### Risk & Uncertainty  
CME’s business is exposed to macro and policy swings. As the company notes, heightened uncertainty (geopolitical, economic) historically *boosts* trading volume (by prompting hedges) ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/1156375/000115637520000013/cme-2019123110k.htm#:~:text=by%20domestic%20and%20international%20factors,are%20beyond%20our%20control%2C%20including)), but the reverse is also true: a stable or rising-rate environment could *reduce* volume and revenue. For example, lower interest rates or comfortable monetary policy might curtail demand for interest-rate futures ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/1156375/000115637520000013/cme-2019123110k.htm#:~:text=by%20domestic%20and%20international%20factors,are%20beyond%20our%20control%2C%20including)). Competition is a major risk factor: CME’s SEC filings specifically warn of “increasing competition…including new entrants” ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/1156375/000115637520000013/cme-2019123110k.htm#:~:text=Among%20the%20factors%20that%20might,affect%20our%20performance%20are)), and we see FMX Futures as a realistic threat. Other uncertainties include regulatory intervention (e.g. market structure changes or antitrust scrutiny), technology disruptions (system outages or cybersecurity attacks on CME Globex), and dependence on customer sentiment (CME noted that shifts in trading patterns since 2008 may not repeat) ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/1156375/000115637520000013/cme-2019123110k.htm#:~:text=by%20domestic%20and%20international%20factors,are%20beyond%20our%20control%2C%20including)). On the ESG front, CME’s environmental footprint is minimal (trading is digital), but data security and ethical oversight are material (the company’s ESG exposure is rated low ([www.sustainalytics.com](https://www.sustainalytics.com/esg-rating/cme-group-inc/1009882823#:~:text=CME%20Group%2C%20Inc,Low)), but risks like software failure remain). In sum, CME faces **Medium** uncertainty: its markets are resilient, but external volatilities or regulatory shifts could significantly swing volumes and valuation.  

### Capital Allocation  
CME’s balance sheet is solid. As of Dec 31, 2023, it held about \$3.1 B in cash ([investor.cmegroup.com](https://investor.cmegroup.com/news-releases/news-release-details/cme-group-inc-reports-fourth-quarter-and-full-year-2023#:~:text=Clearing%20and%20transaction%20fees%20revenue,quarter%202023)) against roughly \$2.7 B in long-term debt (debt/equity ~13.6%) ([finance.yahoo.com](https://finance.yahoo.com/quote/CME/#:~:text=)). This net-cash position gives management flexibility. The company consistently returns cash via a ~2.0% dividend yield ([finance.yahoo.com](https://finance.yahoo.com/quote/CME/#:~:text=,25)) and periodic buybacks. For example, the upcoming sale of its OSTTRA JV is expected to bring ~$1.55 B cash (shared with S&P) ([www.reuters.com](https://www.reuters.com/markets/deals/buyout-firm-kkr-buy-osttra-31-billion-deal-2025-04-14/#:~:text=KKR%20has%20entered%20into%20a,OSTTRA%2C%20headquartered%20in%20London)), which could be redeployed or returned to shareholders. There is no large pending M&A debt or spend. Morningstar notes CME’s capital stewardship is **Standard** (management experienced, prudent in buybacks/dividends) ([tools.morningstar.de](https://tools.morningstar.de/de/stockreport/newsItem.aspx?id=CMS_802670#:~:text=We%20view%20CME%20Group%27s%20stewardship,a%20veteran%20of%20the%20company)). Overall, we see prudent capital allocation: ample cash generation is used for shareholder returns while preserving financial flexibility.  

### Financials Snapshot  

| (USD unless noted)      | FY2022  | FY2023  | FY2024  | FY2025   | FY2026   | FY2027   | FY2028   | FY2029   |
|------------------------:|--------:|--------:|--------:|---------:|---------:|---------:|---------:|---------:|
| Revenue (\$B)          |     5.0 |     5.6 |     6.2 |     6.6  |     7.0  |     7.5  |     8.0  |     8.5  |
| Op. Margin (%)         |    60.0 |    61.0 |    60.0 |    59.0  |    59.0  |    58.5  |    58.0  |    58.0  |
| EPS (\$)               |     7.4 |     8.9 |     9.8 |    10.2  |    10.8  |    11.5  |    12.1  |    12.7  |
| Free Cash Flow (\$B)   |     3.0 |     3.4 |     3.6 |     3.8  |     4.1  |     4.5  |     4.8  |     5.1  |
| ROIC (%)               |    14.0 |    15.0 |    14.5 |    14.0  |    13.5  |    13.0  |    12.5  |    12.0  |

### ESG Risk  
CME’s ESG risk profile is low. Sustainalytics assigns it an overall ESG Risk Score of **18.3 (Low Risk)** ([www.sustainalytics.com](https://www.sustainalytics.com/esg-rating/cme-group-inc/1009882823#:~:text=18)). This is comparable to peer exchanges (ICE: 18.9, Low; Cboe: 21.5, Medium) ([www.sustainalytics.com](https://www.sustainalytics.com/esg-rating/intercontinental-exchange-inc/1008960198#:~:text=18)) ([www.sustainalytics.com](https://www.sustainalytics.com/esg-rating/cboe-global-markets-inc/1040502543#:~:text=21)). The firm’s ESG *exposure* is judged to be low ([www.sustainalytics.com](https://www.sustainalytics.com/esg-rating/cme-group-inc/1009882823#:~:text=CME%20Group%2C%20Inc,Low)), reflecting a non-industrial, data-focused business with minimal direct environmental impact. Its main ESG considerations likely center on data security, system reliability, and governance standards. Sustainalytics notes CME’s management of material risks is “Average” ([www.sustainalytics.com](https://www.sustainalytics.com/esg-rating/cme-group-inc/1009882823#:~:text=CME%20Group%2C%20Inc,ESG%20Material%20Risk%20is%20Average)), meaning there is room to improve formal ESG programs (common in financials). Overall, CME’s ESG controversies are minor: it has no significant incidents on record. In sum, an 18.3 risk score (Low) indicates limited material ESG risk, especially versus many industrial or energy-sector companies.

### Appendix  
**Valuation Assumptions:** Our DCF assumes ~5–7% annual revenue growth (2025–2029), stable fees/contract, and a 60% operating margin. We use a tax rate ~21%, WACC ≈8.5%, and terminal growth ≈3%. **Glossary (Rating Definitions):** *Narrow moat:* A sustainable but modest competitive advantage (vs. wide moat). *Economic Moat:* A company’s durable competitive edge protecting long-term profits. *Uncertainty:** Indicates predictability of cash flows (Low = stable; Medium = cyclicality; High = volatile). *Capital Allocation:* Morningstar’s measure of management’s capital stewardship (‘Standard’ is average; ‘Exemplary’ is top-tier; ‘Poor’ denotes misallocation).  

### Sources  
1. Thomson Reuters – “CME Group’s profit rises as hedging demand lifts trading volume,” Feb 12, 2025.  ([www.reuters.com](https://www.reuters.com/business/finance/cmes-quarterly-profit-jumps-strong-trading-activity-2025-04-23/#:~:text=In%20the%20first%20quarter%20of,million%2C%20largely%20driven%20by%20higher))  
2. Thomson Reuters – “CME Group profit jumps on record trading strength,” Oct 23, 2024.  ([www.reuters.com](https://www.reuters.com/business/finance/cme-group-profit-rises-trading-strength-2024-10-23/#:~:text=to%20%241,rise))  
3. Thomson Reuters – “CME’s profit narrowly misses estimate as higher costs offset trading gains,” Apr 23, 2025.  ([www.reuters.com](https://www.reuters.com/business/finance/cmes-quarterly-profit-jumps-strong-trading-activity-2025-04-23/#:~:text=In%20the%20first%20quarter%20of,million%2C%20largely%20driven%20by%20higher)) ([www.reuters.com](https://www.reuters.com/business/finance/cmes-quarterly-profit-jumps-strong-trading-activity-2025-04-23/#:~:text=rapidly%20evolving%20market,year%20increase.%20Heightened%20trading%20activity))  
4. Thomson Reuters – “BGC Group launches FMX to challenge CME in US Treasuries,” Sep 24, 2024.  ([www.reuters.com](https://www.reuters.com/markets/us/bgc-group-launches-fmx-challenge-cme-us-treasuries-2024-09-24/#:~:text=BGC%20Group%20has%20launched%20its,to%20operate%20in%20January%202024))  
5. Thomson Reuters – “BGC Group’s FMX Futures gets funding from banking consortium,” Apr 25, 2024.  ([www.reuters.com](https://www.reuters.com/business/finance/bgc-groups-fmx-futures-gets-funding-banking-consortium-2024-04-25/#:~:text=BGC%20Group%27s%20FMX%20Futures%20platform,for%20Secured%20Overnight%20Financing%20Rate))  
6. Bloomberg News – “CME, S&P explore sale of joint venture OSTTRA” (report via Reuters), Aug 22, 2024.  ([www.reuters.com](https://www.reuters.com/markets/deals/cme-sp-explore-sale-joint-venture-osttra-bloomberg-news-reports-2024-08-22/#:~:text=CME%20Group%20and%20S%26P%20Global,if%20a%20transaction%20will%20occur))  
7. Thomson Reuters – “KKR signs $3.1 billion deal to buy OSTTRA from S&P Global, CME Group,” Apr 14, 2025.  ([www.reuters.com](https://www.reuters.com/markets/deals/buyout-firm-kkr-buy-osttra-31-billion-deal-2025-04-14/#:~:text=KKR%20has%20entered%20into%20a,OSTTRA%2C%20headquartered%20in%20London))  
8. CME Group – “CME Group Inc. Reports Fourth-Quarter and Full-Year 2023 Financial Results,” Feb 14, 2024 (company press release).  ([investor.cmegroup.com](https://investor.cmegroup.com/news-releases/news-release-details/cme-group-inc-reports-fourth-quarter-and-full-year-2023#:~:text=Total%20revenue%20for%20full,34)) ([investor.cmegroup.com](https://investor.cmegroup.com/news-releases/news-release-details/cme-group-inc-reports-fourth-quarter-and-full-year-2023#:~:text=,new%20products%20and%20increased%20capital))  
9. U.S. SEC – “CME Group Inc. 2019 Annual Report (Form 10-K),” filed Feb 27, 2020 (Risk Factors).  ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/1156375/000115637520000013/cme-2019123110k.htm#:~:text=Among%20the%20factors%20that%20might,affect%20our%20performance%20are)) ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/1156375/000115637520000013/cme-2019123110k.htm#:~:text=by%20domestic%20and%20international%20factors,are%20beyond%20our%20control%2C%20including))  
10. Sustainalytics – “CME Group, Inc. ESG Risk Rating.” Sustainalytics (Morningstar), accessed Apr 2025.  ([www.sustainalytics.com](https://www.sustainalytics.com/esg-rating/cme-group-inc/1009882823#:~:text=18)) ([www.sustainalytics.com](https://www.sustainalytics.com/esg-rating/cme-group-inc/1009882823#:~:text=CME%20Group%2C%20Inc,Low))  
11. Sustainalytics – “Intercontinental Exchange, Inc. ESG Risk Rating.” Sustainalytics, accessed Apr 2025.  ([www.sustainalytics.com](https://www.sustainalytics.com/esg-rating/intercontinental-exchange-inc/1008960198#:~:text=18))  
12. Sustainalytics – “Cboe Global Markets, Inc. ESG Risk Rating.” Sustainalytics, accessed Apr 2025.  ([www.sustainalytics.com](https://www.sustainalytics.com/esg-rating/cboe-global-markets-inc/1040502543#:~:text=21))  
13. Yahoo Finance – “CME Group Inc (CME) Stock Price, News, Quote & History,” accessed Apr 2025.  ([finance.yahoo.com](https://finance.yahoo.com/quote/CME/#:~:text=234.39%20%2B5.02%20%28%2B2.19)) ([finance.yahoo.com](https://finance.yahoo.com/quote/CME/#:~:text=,EPS%20%28TTM%29%209.52)) ([finance.yahoo.com](https://finance.yahoo.com/quote/CME/#:~:text=,25))  
14. Michael Wong, CFA – *CME Group Inc. Company Report*, Morningstar Research, Jul 10, 2017 (stewardship rating).  ([tools.morningstar.de](https://tools.morningstar.de/de/stockreport/newsItem.aspx?id=CMS_802670#:~:text=We%20view%20CME%20Group%27s%20stewardship,a%20veteran%20of%20the%20company))  

*This analysis is for informational purposes only and is not a recommendation to buy or sell any security.*